Avelumab Market Analysis by Application (Merkel-cell Carcinoma, Non-small Cell Lung Carcinoma (NSCLC)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region: Global Forecast, 2024 - 2034

  • 2024-05-29
  • 241
  • Healthcare & Life Sciences

Market Overview

The Avelumab market is predicted to develop at a compound annual growth rate (CAGR) of xx% from 2024 to 2034, when it is projected to reach USD xx Million, based on an average growth pattern. The market is estimated to reach a value of USD xx Million in 2024.

SOURCE: We Market Research

Avelumab is a monoclonal antibody that is used in the immune checkpoint inhibitor family of medications used to treat cancer. It helps the immune system recognize and fight cancer by specifically targeting the PD-L1 protein that is present on some cancer cells. Avelumab interferes with the ability of cancer cells to avoid immune recognition and elimination by blocking PD-L1. Avelumab is a potentially effective therapy option in oncology, having been approved for the treatment of metastatic Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Its mode of action underscores the increasing importance of immunotherapy in the treatment of cancer, providing patients with aggressive cancers with newfound hope.

The global market for Avelumab is driven by multiple significant factors. Demand is fueled by the increasing incidence of cancer, and Avelumab approval for a variety of cancer types expands its potential market. Thanks to favorable regulatory settings globally, targeted medicines like as Avelumab are being backed by advances in immunotherapy, which is changing the paradigm of treatment. Good clinical results boost patient acceptability and physician confidence, which propels market expansion. Pharmaceutical businesses enhance their market presence and accessibility through strategic collaborations. Additionally, Avelumab mode of action is consistent with the move toward individualized therapy. Growing healthcare spending around the world makes it easier to invest in cutting-edge treatments, which propels the market for Avelumab to grow. 

Market Scope

Report Attributes


Market Size in 2024

USD xx Million

Market Forecast in 2034

USD xx Million

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

By Application, By Distribution Channel and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

Avelumab Industry: Dynamics & Restrains

Avelumab Market Dynamics

 Market opportunity:

Avelumab Market Opportunity

We Market Research: Avelumab Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Avelumab Market

Avelumab Segmentation

Market- By Application Analysis

By Application, the Avelumab Market is Categories into Merkel-cell Carcinoma, Non-small Cell Lung Carcinoma (NSCLC). The Merkel-cell Carcinoma segment accounts for the largest share of around 78% in 2024.

Avelumab Market Segmentation

Merkel-cell Carcinoma's prominence is propelled by rising incidence rates globally, likely due to factors such as increased UV radiation exposure, aging populations, and immunosuppression. Advanced treatments like Avelumab offer promising therapeutic avenues, driving further research and market growth.

The following segments are part of an in-depth analysis of the global Avelumab market:

Market Segments


By Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies


Avelumab Industry: Regional Analysis

North America Market Forecast

North America dominate the Avelumab Market with the highest revenue generating market with share of more than 49%. North America is known for its cutting-edge healthcare system and large R&D expenditures. Avelumab is widely used in the treatment of NSCLC and Merkel-cell carcinoma, due to favorable reimbursement policies, which propel the expansion of the regional market.

Avelumab Market Regional Outlook

Europe Market Statistics

Europe is the second largest region in Avelumab market. The safety and quality of products are guaranteed by Europe's strict regulatory standards. Due to the high incidence of NSCLC and Merkel-cell carcinoma, the area has a substantial need for Avelumab, which is backed by strong clinical research efforts and robust healthcare infrastructures.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Avelumab market during the forecast period. In the Asia Pacific region, the Asia-Pacific Avelumab market is growing due to expanding immunotherapy awareness and rising healthcare spending. Countries in the region are seeing an increase in the use of cutting-edge medicines due to a rising incidence of cancer, especially NSCLC and Merkel-cell carcinoma. This trend is being aided by advancements in healthcare infrastructure.

Key Market Players

The Avelumab Market is dominated by a few large companies, such as

·         Merck

·         Pfizer

·         Others

1.      Global Avelumab Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Avelumab Market Scope and Market Estimation

1.2.1. Global Avelumab Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Avelumab Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Application of Global Avelumab Market

1.3.2. Distribution Channel of Global Avelumab Market

1.3.3. Region of Global Avelumab Market

2.      Executive Summary

2.1.    Global Avelumab Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Avelumab Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Porter’s Five Forces Analysis

2.3.1. Bargaining Power of Suppliers

2.3.2. Bargaining Power of Buyers

2.3.3. Threat of Substitutes

2.3.4. Threat of New Entrants

2.3.5. Competitive Rivalry

2.4.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Avelumab Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Avelumab Market Estimates & Forecast Trend Analysis, by Application

4.1.    Global Avelumab Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

4.1.1. Merkel-cell Carcinoma

4.1.2. Non-small Cell Lung Carcinoma (NSCLC)

5.      Global Avelumab Market Estimates & Forecast Trend Analysis, by Distribution Channel

5.1.    Global Avelumab Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

5.1.1. Hospital Pharmacies

5.1.2. Retail Pharmacies

5.1.3. Online Pharmacies

6.      Global Avelumab Market Estimates & Forecast Trend Analysis, by Region

6.1.    Global Avelumab Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

6.1.1. North America

6.1.2. Europe

6.1.3. Asia Pacific

6.1.4. Middle East & Africa

6.1.5. South America

7.      North America Avelumab Market: Estimates & Forecast Trend Analysis

7.1.    North America Avelumab Market Assessments & Key Findings

7.1.1. North America Avelumab Market Introduction

7.1.2. North America Avelumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By Application   By Distribution Channel   By Country     The U.S.     Canada     Mexico

8.      Europe Avelumab Market: Estimates & Forecast Trend Analysis

8.1.    Europe Avelumab Market Assessments & Key Findings

8.1.1. Europe Avelumab Market Introduction

8.1.2. Europe Avelumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By Application   By Distribution Channel        By Country     Germany     U.K.     France     Italy     Spain     Russia     Rest of Europe

9.      Asia Pacific Avelumab Market: Estimates & Forecast Trend Analysis

9.1.    Asia Pacific Market Assessments & Key Findings

9.1.1. Asia Pacific Avelumab Market Introduction

9.1.2. Asia Pacific Avelumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By Application   By Distribution Channel        By Country     China     Japan     India     Australia     South Korea     ASEAN     Rest of Asia Pacific

10.  Middle East & Africa Avelumab Market: Estimates & Forecast Trend Analysis

10.1.  Middle East & Africa Market Assessments & Key Findings

10.1.1.   Middle East & Africa Avelumab Market Introduction

10.1.2.   Middle East & Africa Avelumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By Application    By Distribution Channel    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

11.  South America Avelumab Market: Estimates & Forecast Trend Analysis

11.1.  South America Market Assessments & Key Findings

11.1.1.   South America Avelumab Market Introduction

11.1.2.   South America Avelumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By Application    By Distribution Channel    By Country Brazil Argentina Colombia Rest of South America

12.  Competition Landscape

12.1.  Global Avelumab Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

12.2.  Global Avelumab Market Competition White Space Analysis, By End-user

12.3.  Global Avelumab Market Competition Heat Map Analysis, By End-user

12.4.  Global Avelumab Market Concentration & Company Market Shares (%) Analysis, 2022

13.  Company Profiles

13.1.                     Merck.

13.1.1.   Company Overview & Key Stats

13.1.2.   Financial Performance & KPIs

13.1.3.   Product Portfolio

13.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

13.2.      Pfizer

13.3.      Others

14.  Research Methodology

14.1.  External Transportations / Databases

14.2.  Internal Proprietary Database

14.3.  Primary Research

14.4.  Secondary Research

14.5.  Assumptions

14.6.  Limitations

14.7.  Report FAQs

15.  Research Findings & Conclusion


Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Avelumab Market in 2024?

Avelumab Market was valued at USD xx Million in 2024.

What is the growth rate for the Avelumab Market?

Avelumab Market size will increase at approximate CAGR of xx% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Avelumab Market Are Merck, Pfizer and Other.

Which region dominates the Avelumab Market?

North America dominates the market with an active share of 49%.


Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI